Verdad Advisers »

Enliven Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $861k 17k 50.75